-
81.发明授权락토코쿠스 락티스(Lactococcus lactis)를 유효성분으로 포함하는 Th1-매개 면역 질환, Th17-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 有权乳酸乳球菌楠鼻部（乳酸乳球菌）一个Th1-介导的，它包括作为活性成分的Th17免疫疾病 - 介导的免疫疾病或Th2-介导预防自身免疫性疾病的，用于改善或治疗的组合物
公开(公告)号：KR101724126B1
公开(公告)日：2017-04-10
申请号：KR1020150114937
申请日：2015-08-13
Applicant: 한국식품연구원
IPC: A61K35/744 , A61K8/99 , A23K1/00 , A23L1/30
Abstract: 본발명은락토코쿠스락티스()를유효성분으로포함하는 Th1-매개면역질환, Th17-매개면역질환또는 Th2-매개면역질환의예방, 개선또는치료용조성물에관한것이다. 본발명의락토코쿠스락티스는면역글로불린 E(IgE)의생성을감소시키고, 면역과민반응시 Th1-관련사이토카인, Th17-관련사이토카인및 Th2-관련사이토카인생성을감소시킴으로써 Th1-매개면역질환, Th17-매개면역질환또는 Th2-매개면역질환을효과적으로제어하는바항알레르기성또는항염증조성물로사용이가능한이점이있다.
Abstract translation: 本发明涉及一种鼻子乳杆菌楠Th1-介导的免疫病，自身免疫性疾病或Th2-介导预防Th17-免疫介导的疾病的，改善或治疗性组合物，包括作为活性成分，所述锁齿（）。 本发明的乳酸乳球菌乳脂楠鼻子降低生产免疫球蛋白E的（IgE）的，免疫超敏反应当Th1-相关的细胞因子，Th17-通过减少相关的细胞因子和Th2-相关的细胞因子的产生介导的免疫Th1- 疾病，巴巷点可用于由过敏或抗炎组合物中使用有效控制的Th17 - 介导的免疫疾病或Th2-介导的免疫疾病。
-
公开(公告)号：KR101707673B1
公开(公告)日：2017-02-20
申请号：KR1020160016480
申请日：2016-02-12
Applicant: 한국식품연구원
Abstract: 본발명은석류풀() 추출물, 질경이택사() 추출물, 담팥수() 추출물및 개승마() 추출물로구성된군으로부터선택되는하나이상의추출물을유효성분으로포함하는 Th2-매개면역질환의예방, 개선또는치료용조성물에관한것이다. 본발명에따르면, 상기추출물은 IL-4 생성억제및 비만세포의탈과립억제활성을가짐으로 Th2-매개면역질환을예방, 개선또는치료할수 있다.
Abstract translation: 本发明涉及一种用于预防，减轻或治疗Th2介导的免疫疾病的组合物，其包含一种或多种选自以下的一种或多种：莫洛氏五叶提取物，水蚤植物，水an螨，E ris提取物和仙客来 提取物，作为活性成分。 根据本发明，提取物具有通过抑制IL-4产生和肥大细胞脱粒的活性来预防，减轻或治疗Th2介导的免疫疾病的作用。
-
公开(公告)号：KR101631314B1
公开(公告)日：2016-06-20
申请号：KR1020150107305
申请日：2015-07-29
Applicant: 한국식품연구원
Abstract: 본발명은백부근(), 상심자(), 세신() 및정공등()으로구성된군으로부터선택되는하나이상의천연물의천연물추출물을유효성분으로포함하는 Th2-매개면역질환의예방, 개선또는치료용조성물에관한것이다. 본발명에따르면, 상기천연물추출물은 IL-4 생성및 비만세포의탈과립억제효과를가짐으로 Th2-매개면역질환을예방, 개선또는치료할수 있다.
-
84.发明授权옥촉서예, 유향 또는 상지의 추출물을 포함하는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 有权用于预防，改善或治疗Th2介导的免疫疾病的组合物，其包含来自玉米，卡氏芥子或桑ing的提取物
公开(公告)号：KR101471032B1
公开(公告)日：2014-12-10
申请号：KR1020130023980
申请日：2013-03-06
Applicant: 한국식품연구원
IPC: A61K36/324 , A61K36/605 , A61P37/00
Abstract: 본발명은옥촉서예(), 유향() 및상지()로구성된군으로부터선택되는하나이상의천연물의천연물추출물을유효성분으로포함하는 Th2-매개면역질환의예방, 개선또는치료용조성물에관한것이다. 본발명에따르면, 상기천연물추출물은 IL-4 생성및 비만세포의탈과립의억제효과를가짐으로 Th2-매개면역질환을예방, 개선또는치료할수 있다.
-
Patent Agency Ranking85.发明公开옥촉서예, 유향 또는 상지의 추출물을 포함하는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 无效用于预防，改善或治疗包含来自ZEA MAYS，BOSWELLIA CARTERII或MORUS ALBA的提取物的TH2介导的免疫疾病的组合物
公开(公告)号：KR1020140111231A
公开(公告)日：2014-09-18
申请号：KR1020140089809
申请日：2014-07-16
Applicant: 한국식품연구원
IPC: A61K36/605 , A61P37/08 , A61P37/00
CPC classification number: A61K36/899 , A23V2200/304 , A23V2200/324 , A61K36/324 , A61K36/605 , Y10S514/885
Abstract: The prevention relates to a composition for the prevention, alleviation or treatment of a Th2-mediated immune disease, the composition including, as an active ingredient, an extract of at least one natural substance selected from the group consisting of Zea mays, Boswellia carterii and Morus alba. According to the present invention, the extract of a natural substance has inhibitory effects against the generation of IL-4 and the degranulation of mast cells, and thus can prevent, alleviate or treat a Th2-mediated immune disease.
Abstract translation: 预防涉及用于预防，减轻或治疗Th2介导的免疫疾病的组合物，该组合物包含至少一种天然物质的提取物作为活性成分，所述天然物质选自玉米，卡氏芥子和 桑 根据本发明，天然物质的提取物具有抑制IL-4的产生和肥大细胞脱颗粒的作用，因此可以预防，缓解或治疗Th2介导的免疫疾病。
-
86.发明公开옥촉서예, 유향 또는 상지의 추출물을 포함하는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 有权用于预防，改善或治疗包含来自ZEA MAYS，BOSWELLIA CARTERII或MORUS ALBA的提取物的TH2介导的免疫疾病的组合物
公开(公告)号：KR1020140111099A
公开(公告)日：2014-09-18
申请号：KR1020130023980
申请日：2013-03-06
Applicant: 한국식품연구원
IPC: A61K36/324 , A61K36/605 , A61P37/00
Abstract: The prevention relates to a composition for the prevention, alleviation or treatment of a Th2-mediated immune disease, which comprises, as an active ingredient, an extract of at least one natural substance selected from the group consisting of Zea mays, Boswellia carterii and Morus alba. According to the present invention, the extract of a natural substance has inhibitory effects against the generation of IL-4 and the degranulation of mast cells and thus can prevent, alleviate or treat a Th2-mediated immune disease.
Abstract translation: 预防涉及用于预防，减轻或治疗Th2介导的免疫疾病的组合物，其包含至少一种天然物质的提取物作为活性成分，所述天然物质选自玉米，卡氏芥子和桑树 阿尔巴。 根据本发明，天然物质的提取物具有抑制IL-4的产生和肥大细胞脱粒的作用，因此可以预防，缓解或治疗Th2介导的免疫疾病。
-
87.发明公开복령피 추출물을 유효성분으로 포함하는 Ｔｈ1-매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 有权用于预防，改善或治疗TH1介导的免疫疾病或包含来自PORIA COCOS WOLF作为活性成分的提取物的TH2介导的免疫疾病的组合物
公开(公告)号：KR1020140074146A
公开(公告)日：2014-06-17
申请号：KR1020130012031
申请日：2013-02-01
Applicant: 한국식품연구원
IPC: A61K36/076 , A61K36/07 , A61P3/04 , A61P3/00
Abstract: The present invention relates to a composition comprising Poria cocos extract as an active ingredient for preventing, alleviating, or treating a Th1-mediated immune diseases or Th2-mediated immune diseases. According to the present invention, the Poria cocos extract has activities for inhibiting production of IL-4 and IL-10, inhibiting degranulation of mast cells, inducing differentiation to Treg cells, and stabilizing Treg cells, thereby preventing, alleviating, or treating the Th1-mediated immune diseases or the Th2-mediated immune diseases.
Abstract translation: 本发明涉及包含茯苓提取物作为预防，减轻或治疗Th1介导的免疫疾病或Th2介导的免疫疾病的活性成分的组合物。 根据本发明，茯苓提取物具有抑制IL-4和IL-10产生的作用，抑制肥大细胞脱颗粒，诱导Treg细胞分化，稳定Treg细胞，从而预防，减轻或治疗Th1 介导的免疫疾病或Th2介导的免疫疾病。
-
88.发明公开감송향 추출물을 유효성분으로 포함하는 Ｔｈ1－매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물 无效用于预防，改善或治疗TH1介导的免疫疾病或包含NARDOSTACHYS JATAMANSE作为活性成分的提取物的TH2介导的免疫疾病的组合物
公开(公告)号：KR1020140073723A
公开(公告)日：2014-06-17
申请号：KR1020120141329
申请日：2012-12-06
Applicant: 한국식품연구원
Abstract: The present invention relates to a composition comprising Nardostachys jatamanse extract as an active ingredient for preventing, alleviating, or treating a Th1-mediated immune disease or a Th2-mediated immune disease. According to the present invention, the Nardostachys jatamanse extract has IL-4 inhibition, degranulation inhibition of mast cells, and differentiation to Treg cells inducing activities, thereby capable of preventing, alleviating, or treating the Th1-mediated immune disease or the Th2-mediated immune disease.
Abstract translation: 本发明涉及包含Nardostachys jatamanse提取物作为预防，减轻或治疗Th1介导的免疫疾病或Th2介导的免疫疾病的活性成分的组合物。 根据本发明，Nardostachys jatamanse提取物具有IL-4抑制，肥大细胞的脱颗粒抑制，以及诱导Treg细胞诱导活性的分化，从而能够预防，减轻或治疗Th1介导的免疫疾病或Th2介导的 免疫疾病。
-
公开(公告)号：KR1020130110010A
公开(公告)日：2013-10-08
申请号：KR1020130018895
申请日：2013-02-21
Applicant: 한국식품연구원
CPC classification number: A61K36/48 , A23L11/09 , A23V2200/324 , A61K2236/19 , A61K2236/333 , Y10S514/885
Abstract: PURPOSE: A systemic immunity or intestinal immunity adjuvant containing a Cheonggukjang extract as an active ingredient is provided to induce Th1 and Th2 responses against parenteral infectious pathogenic microorganisms, virus, cancer antigens, and general antigens as well as oral infectious pathogenic microorganisms during oral administration and to effectively produce a specific antibody. CONSTITUTION: A systemic immunity or intestinal immunity adjuvant contains a Cheonggukjang extract as an active ingredient. The Cheonggukjang extract contains an ethanol soluble ingredient which is prepared using ethanol. The ethanol is 50-99 % ethanol. The Cheonggukjang extract does not contain poly-gamma-glutamic acid (PGA) and levan. Cheonggukjang is prepared using Bacillus amyloliquefaciens. [Reference numerals] (AA,DD) Water extract; (BB) Bean; (CC,FF) 70%EtOH extract; (EE) Cheonggukjang
Abstract translation: 目的：提供含有Cheonggukjang提取物作为活性成分的全身免疫或肠道免疫佐剂，以在口服给药期间诱导针对胃肠外感染性致病微生物，病毒，癌抗原和一般抗原以及口腔感染性病原微生物的Th1和Th2应答， 以有效地产生特异性抗体。 构成：全身免疫或肠道免疫佐剂含有Cheonggukjang提取物作为活性成分。 清胃ang提取物含有乙醇可溶成分，用乙醇制备。 乙醇为50-99％乙醇。 清胃ang提取物不含聚-γ-谷氨酸（PGA）和果糖。 使用解淀粉芽孢杆菌制备清uk。。 （参考号）（AA，DD）水提取物; （BB）豆; （CC，FF）70％EtOH提取物; （EE）Cheonggukjang
-
-
-
-
-
-
-
-
Search Results
89
records
(took 0.029 seconds)
